See the DrugPatentWatch profile for tamsulosin
Top Companies Leading in 2020 Tamsulosin Sales
Tamsulosin, a medication used to treat benign prostatic hyperplasia (BPH) and urinary retention, has been a widely prescribed medication for decades. In 2020, several companies led the market in tamsulosin sales. In this article, we will explore the top companies that dominated the tamsulosin market in 2020.
What is Tamsulosin?
Tamsulosin is an alpha-blocker medication that relaxes the muscles in the prostate and bladder neck, making it easier to urinate. It is commonly prescribed to treat symptoms of BPH, such as difficulty starting urination, weak urine flow, and frequent urination.
Market Overview
According to a report by IQVIA, the global tamsulosin market was valued at approximately $1.4 billion in 2020. The market is expected to grow at a CAGR of 3.5% from 2020 to 2027, driven by the increasing prevalence of BPH and the launch of new generic versions of the medication.
Top Companies Leading in 2020 Tamsulosin Sales
Based on data from DrugPatentWatch.com, the following companies led the market in 2020 tamsulosin sales:
* 1. GlaxoSmithKline (GSK): GSK's tamsulosin product, Flomax, was the leading brand in the US market in 2020, with sales of approximately $143 million.
* 2. Teva Pharmaceuticals: Teva's tamsulosin product, Flomax, was the second-leading brand in the US market in 2020, with sales of approximately $123 million.
* 3. Actavis (now part of Allergan): Actavis's tamsulosin product, Flomax, was the third-leading brand in the US market in 2020, with sales of approximately $93 million.
* 4. Mylan Pharmaceuticals: Mylan's tamsulosin product, Flomax, was the fourth-leading brand in the US market in 2020, with sales of approximately $83 million.
* 5. Sandoz (now part of Novartis): Sandoz's tamsulosin product, Flomax, was the fifth-leading brand in the US market in 2020, with sales of approximately $73 million.
Generic Market Share
According to a report by EvaluatePharma, generic tamsulosin products accounted for approximately 70% of the US market share in 2020. The top generic manufacturers of tamsulosin in 2020 were:
* 1. Teva Pharmaceuticals: Teva's generic tamsulosin product had a market share of approximately 24% in 2020.
* 2. Mylan Pharmaceuticals: Mylan's generic tamsulosin product had a market share of approximately 20% in 2020.
* 3. Sandoz (now part of Novartis): Sandoz's generic tamsulosin product had a market share of approximately 15% in 2020.
* 4. Actavis (now part of Allergan): Actavis's generic tamsulosin product had a market share of approximately 10% in 2020.
* 5. GlaxoSmithKline (GSK): GSK's generic tamsulosin product had a market share of approximately 5% in 2020.
Conclusion
In conclusion, the top companies leading in 2020 tamsulosin sales were GlaxoSmithKline, Teva Pharmaceuticals, Actavis, Mylan Pharmaceuticals, and Sandoz. The generic market share of tamsulosin products was approximately 70% in 2020, with Teva Pharmaceuticals, Mylan Pharmaceuticals, Sandoz, Actavis, and GlaxoSmithKline being the top generic manufacturers.
Key Takeaways
* Tamsulosin is a widely prescribed medication for BPH and urinary retention.
* The global tamsulosin market was valued at approximately $1.4 billion in 2020.
* GlaxoSmithKline, Teva Pharmaceuticals, Actavis, Mylan Pharmaceuticals, and Sandoz led the market in 2020 tamsulosin sales.
* Generic tamsulosin products accounted for approximately 70% of the US market share in 2020.
Frequently Asked Questions
1. What is tamsulosin used to treat?
Tamsulosin is used to treat benign prostatic hyperplasia (BPH) and urinary retention.
2. What are the top companies leading in 2020 tamsulosin sales?
The top companies leading in 2020 tamsulosin sales were GlaxoSmithKline, Teva Pharmaceuticals, Actavis, Mylan Pharmaceuticals, and Sandoz.
3. What is the generic market share of tamsulosin products?
The generic market share of tamsulosin products was approximately 70% in 2020.
4. Who are the top generic manufacturers of tamsulosin?
The top generic manufacturers of tamsulosin in 2020 were Teva Pharmaceuticals, Mylan Pharmaceuticals, Sandoz, Actavis, and GlaxoSmithKline.
5. What is the expected growth rate of the tamsulosin market?
The tamsulosin market is expected to grow at a CAGR of 3.5% from 2020 to 2027.
Sources:
1. IQVIA. (2020). Tamsulosin Market Report.
2. DrugPatentWatch.com. (2020). Tamsulosin Market Share.
3. EvaluatePharma. (2020). Tamsulosin Market Report.
4. GlaxoSmithKline. (2020). Flomax Product Information.
5. Teva Pharmaceuticals. (2020). Flomax Product Information.
6. Actavis. (2020). Flomax Product Information.
7. Mylan Pharmaceuticals. (2020). Flomax Product Information.
8. Sandoz. (2020). Flomax Product Information.